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ACOUSTIC STARTLE RESPONSE AFFECTED BY AGING AND
CHOLINERGIC NEUROTRANSMITTERS




The acoustic startle response has been used to evaluate tinnitus and hyperacusis in animal models. Gap induced prepulse in-
hibition of the acoustic startle reflex (gap-PPI) is affected by tinnitus and loudness changes. Since tinnitus and reduced sound
tolerance are commonly seen in elderly, we measured gap-PPI in Fischer 344 rats, an aging related hearing loss model, at dif-
ferent ages: 3-5 months, 9-12 months, and 15-17 months. The startle response was induced by three different intensity of
sound: 105, 95 and 85 dB SPL. Gap-PPI was induced by different duration of silent gaps from 1 to 100 ms. When the startle
was induced by 105 dB SPL sound intensity, the gap-PPI induced by 50 ms silent gap was significantly lower than those in-
duced by 25 or 100 ms duration, showing a“notch”in the gap-PPI function. The“notch”disappeared with the reduction of
startle sound, suggesting the“notch”may be related with hyper-sensitivity to loud sound. As the intensity of the stimulus de-
creased, the appearance of the hyperacusis-like effect decreased more quickly for the youngest group of rats. We also tested
scopolamine, a muscarinic acetylcholine receptor antagonist, and mecamylamine, a nicotinic acetylcholine receptor antago-
nist, on the effect of gap-PPI. When scopolamine was administered, the results indicated no addition effect on the hyperacu-
sis-like phenomenon in the two older groups. Mecamylamine, the nicotinic antagonist also showed effects on the appearance
of hyperacusis on rats in different ages. The information derived from the study will be fundamental for the further research in
determining the cause and treatment for hyperacusis.
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Introduction
Hyperacusis, an unusual intolerance to environmental
sound seen in children and adults, is a commonly report-
ed disorder that has received very little attention[1]. This
disorder has been described in a variety of pathologies
including acoustic trauma, stapedectomy, Williams syn-
drome in children, migraine attacks, facial paralysis,
autistic spectrum disorder and tinnitus[2]. Currently, the
prevalence of hyperacusis is 9-15% in the general pop-
ulation and markedly increased in the tinnitus popula-
tion [3]. The limited attention to hyperacusis in the liter-
ature greatly contrasts the large number of hyperacusis
patients who suffer from this disorder[2]. The lack of
attention may be partly due to the lack of animal mod-
el in which the neuromechanism of this disorder can
be studied [4].
Currently, in the clinical setting, the Loudness Dis-
comfort Level (LDL) is the most widely used subjec-
tive method of measuring hyperacusis in human sub-
jects. However, some studies found the LDL did not
match the patient’s complains on hyperacusis[5]. Loud-
ness growth function is another subjective measure
whereby the subject uses a fractionation method of ad-
justment procedure to adjust the loudness level in the
test ear to equal two times the loudness level of the
reference ear [6]. However, both these tests can be se-
verely affected by the patients’subjective factors.
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The acoustic startle reflex is a contraction of mus-
cles in response to a sound of high intensity which can
be used to measure the behavioral response to sound
in animals. Previous studies have indicated that indi-
viduals complaining of suprathreshold hyperacusis with
a probable neurochemical etiology, show abnormally
low acoustic reflex thresholds when compared to nor-
mal subjects. With more study in this area, acoustic re-
flex testing could become more critical in the evalua-
tion of hyperacusis and its origin. Ison et al. recently
reported that aging induced hyperacusis could be mea-
sured using the startle reflex facilitation in mice [7].
The idea of facilitation of startle reflex is the founding
principle for measuring hyperacusis through use of star-
tle reflex testing. Facilitation occurs when the animal
responds more to the startle stimulus as they age or as
the intensity of the startle stimulus increases[7]. When pre-
ceding the startle stimuli by another stimulus, either a
narrowband noise or a silent interval, the startle reflex
is suppressed[8]. This phenomenon is known as prepulse
inhibition and is seen through narrowband prepulse inhi-
bition (NB-PPI) testing and gap prepulse inhibition
(Gap-PPI) testing. The Gap-PPI paradigm allows us to
see an interaction between facilitation and inhibition to
the startle stimulus (reaction to the stimulus) when the
intensity of the startle stimulus decreases.
Fischer 344 rats have been shown to develop aging
related hearing loss much more quickly than other
strains of rats. According to Bielefeld et al., Fischer
344 rats begin to develop an aging related hearing loss
at 12 months. Auditory brainstem response (ABR) re-
sults indicate a significant hearing loss of 50-60 dB
SPL for 20 to 40 kHz and a 20 dB SPL loss for 5-10
kHz in 24 months old Fischer 344 rats. The facilita-
tion of the startle reflex at 50 ms and the progression
of hearing loss in Fischer 344 rats provide an exempla-
ry animal model for testing aging induced hyperacusis
(or tinnitus) through the use of startle reflex. With the
possibility of a novel and valid method of detecting hy-
peracusis in an animal model, there are endless possi-
bilities for discovering the site, cause and treatments
for this disorder.
Hyperacusis can be found in several different popula-
tions. Considering that hyperacusis is often related to
tinnitus and tinnitus is often associated with sensorineu-
ral hearing loss, research involving aging-related hear-
ing loss could provide insight into the etiology of hy-
peracusis. Sensorineural hearing loss is associated
with reorganization in the central auditory system and
this reorganization is thought to be associated with the
development of tinnitus and hyperacusis. Dr. Ison’s
study pertaining to hearing loss showed hyperacusis
like behavior in old mice in the low frequencies. The
hyperacusis effect was pronounced by a delayed exag-
geration of the acoustic startle reflex in these mice
with age-related hearing loss. This suggests a useful
model for detecting tinnitus and central hyperacusis in
animals with age-related hearing loss may be through
acoustic startle reflex testing[7].
In the auditory system, when a hearing loss is pres-
ent, the signal sent through neurotransmitters is re-
duced and some synapses are no longer stimulated.
This reduction in stimulation leads to reorganization of
the central system to which these signals were previ-
ously sent. When hyperacusis or tinnitus presents as a
possible result of this reorganization, it is plausible to
relate the change in neurotransmitter release to the de-
velopment of tinnitus or hyperacusis. Some of the most
common neurotransmitters related to the auditory system
are found in cholinergic receptors[9]. A current area of in-
terest in tinnitus research is the cholinergic receptor influ-
ence on tinnitus behavior. Previous studies have found
that tinnitus may be related to spontaneous activity in
the dorsal cochlear nucleus[10,11]. Cholinergic receptors
have been found in the cochlear nucleus[12,13] indicating
that changes in acetylcholine receptors may affect spon-
taneous activity at this region and therefore affect
symptoms such as tinnitus and hyperacusis. Acetylcho-
line receptor antagonists could block the effects found
in the cochlear nucleus that occurs in conjunction with
tinnitus and hyperacusis whereby eliminating the per-
ception of these disorders. As the prevalence of hyper-
acusis in patients with continuous tinnitus is as high as
80% [2], the apparent link between these two disorders
has led to the speculation of common mechanisms.
Materials and methods
Animals: Fischer 344 rats, both male and female,
were assigned into three groups: rats ages 3-5 months
old (n = 6), rats ages 9-12 months old (n = 5), and
rats ages 15-17 months old (n = 5). Each group of
rats went through the same series of testing. Acoustic
startle reflex testing included NB-PPI and gap-PPI at a
normal presentation level (105 dB SPL) and two re-
duced intensity presentations levels (10 dB SPL re-
duced and 20 dB SPL reduced). Drug testing included
three consecutive days of subcutaneous injections of
Scopolamine (0.5 mg/kg). On a separate occasion, at
least one week after scopolamine injections, three con-
secutive days of subcutaneous injections of mecamyla-
mine (3 mg/kg) were administered. Scopolamine was
diluted to 2 mg/ml and mecamylamine was diluted to
1 mg/ml.
Acoustic Startle Reflex Testing Apparatus: Gap in-
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duced prepulse and narrow band prepulse were both
designed to monitor the prepulse inhibition of acoustic
startle reflex phenomena[14,15]. The testing procedure
was conducted using a wire mesh cage secured on a
plexi-glass surface that rested on a piezoelectric trans-
ducer (Radio Shack Corp.). The wire mesh cage
(15-20cm L×7cm W ×5.5cm H) provided a stable hold-
ing facility for the rats, in which their movements
were restricted within the calibrated sound field (Lar-
son Davis, 824). Sound signals were generated by a
RP2 Real-time Processor (Tucker-Davis Technologies
(TDT, FL) from a custom program created in MatLab.
These signals were presented by a high frequency
speaker (FT28D, Fostex) located 20 cm above the rats.
The startle stimulus consisted of a broadband noise
burst presented at 95 dB SPL (0.5 to 30 kHz, 20 ms
duration, 0.1 ms rise/fall time). Once the rat respond-
ed, the output created by the transducer was sent to a
1000 Hz low pass filter (LPF-300 World Precision In-
struments) and then to an A/D converter on a RP2 Re-
al-time Processor. The root mean square (RMS) am-
plitude was automatically measured over the 100 ms
following the onset of the startle stimulus.
GAP-PPI Testing Procedure: Acoustic startle re-
flexes were measured for all three groups of rats at a
normal presentation level, two presentation levels with
reduced intensity, and after administration of two drugs
using two different testing procedures: Gap-PPI and
NB-PPI. The gap detection paradigm involved a con-
tinuously presented white noise at a suprathreshold lev-
el of 60 dB SPL. During each trial, there was a gap
in the white noise in which no sound was presented.
This gap duration varied from 1 to 100 ms over the
course of the 44 minute test. At 60 ms after the offset
of the gap, a startle sound was presented. This testing
procedure is illustrated in Figure 1C-D. This study al-
so called for presentation of the startle sound to be re-
duced to 95 dB SPL and 85 dB SPL for specific parts.
There was an average of 20 second intervals between
each trial. The entire test contained ten trials for each
condition, some containing no gaps and some contain-
ing gaps with durations of 1, 2, 4, 6, 8, 10, 15, 25, 50,
100 ms. Trials were presented in a random order. The
RMS amplitude was measured in the presence of con-
tinuous noise with no gap (STng) or continuous noise
with a gap (STg). When a gap preceded a startle
sound, it inhibited the bodily response in normal hear-
ing rats. The extent of gap-PPI in percentage was de-
fined as: (STng-STg)/STng x 100%. The gap detection
threshold (GDT) was defined by the shortest gap capa-
ble of suppressing the startle reflex by a significant
margin compared to the no-gap condition where there
was no suppression of the startle reflex.
NB-PPI Testing Procedure (NB-PPI): When run-
ning the NB-PPI procedure, the startle stimulus was
presented alone or following a 60 dB SPL narrowband
noise burst (1000 Hz bandwidth, 50 ms with 1 ms rise/
fall time). The testing procedure is illustrated in Fig-
ure 1E-F. The noise-bursts were centered on 6, 12, 16,
20 and 24 kHz. If the 60 dB SPL noise burst was
used, it preceded the startle stimulus by 60 ms. The
RMS amplitude was measured in quiet (STq) or with a
preceding noise-burst (STnb). Compared to the quiet
measurement, the preceding noise-burst was intended
to reduce the amplitude of the startle response. The ex-
tent of NB-PPI in percentage was defined as:
(STq-STnb)/(STq)×100%. STq and STnb were present-
ed in pairs in a random order. Each pair was present-
ed at each frequency.
Acetylcholine Antagonist Testing: Each group re-
ceived subcutaneous injections of scopolamine (0.5 mg/
kg, S0929 Sigma-Aldrich), once at 30 minutes before
startle reflex testing. This procedure was carried out
for three consecutive days. The same procedure was
also conducted for mecamylamine (3 mg/kg, M9020
Sigma-Aldrich) at another time point during the study.
A time of at least one week was observed between ad-
ministrations of the two drugs to eliminate any overlap
of drug effect on testing. Both drugs were diluted us-
ing saline. Scopolamine was diluted to 2 mg/ml and
mecamylamine was diluted to 1 mg/ml before injec-
tions. Thirty minutes after injections, each group un-
derwent gap-PPI and NB-PPI testing using the proce-
dure previously mentioned. About one and a half
hours was needed to conduct all testing on each day.
Statistical Methods: Statistical analysis was carried
out using the GraphPad Prism version 5.00 for Win-
dows (GraphPad Software, San Diego, CA). An un-
paired t-test was used to evaluate the significance of
the prepulse inhibition induced by a 50 ms gap com-
pared to the adjacent gap durations. Variability was in-
dicated by standard error of the mean.
Results
Acoustic startle response and gap detection: The
startle amplitude-level function illustrates the effect of
sound intensity on startle amplitude in Fischer 344
rats. The general trend noted in Figure 1B indicates
that with an increase in sound intensity, startle ampli-
tude increases. At above 80 dB SPL, a reliable startle
response can be elicited. The current data was collect-
ed using a wideband noise, therefore, involving a wide
range of frequencies. This result was used to deter-
mine the sound level used for inducing a reliable star-
75
2014 Vol.9 No.2
tle response in the gap-PPI test. Our results indicate
that all rats had appropriate startle response needed to
accurately administer the Gap-PPI test. Figure 2A and
2B show the NB-PPI and gap-PPI results in different age
groups.A white-band noise burst at 105 dB SPL was
used to induce startle response during the test. The level
of prepulse sound was 60 dB SPL. In all three groups,
NB-PPI showed robust amplitude at above 40% inhibi-
tion. In gap-PPI test, there was no significant difference
in three groups.
Reduction in startle stimulus: To determine the ef-
fects of stimulus level on gap-PPI, results of gap-PPI
testing were recorded for three different stimulus levels:
105 dB SPL, 95 dB SPL and 85 dB SPL. The gap
pre-pulse, found in the Gap-PPI procedure, is meant to
inhibit the startle reflex elicited by a loud sound. Figure
3 shows the baseline (95 dB SPL stimulus) Gap-PPI re-
sults for 3-5 month olds, 9-12 month olds and 15-17
month olds. Gap-PPI results were considered normal for
all groups in baseline testing. The 3-5 month old group
displayed the greatest inhibition at 73%, while the 9-12
month group peaked at 77% and the oldest group at
63%. For baseline testing with a startle stimulus at 105
dB SPL, all three groups showed a significant difference
in pre-pulse inhibition from the 50 ms gap duration to
the 100 ms gap duration (unpaired t-test) on Day 3 (D3)
of testing. Inhibition was significantly less at the 50 ms
gap compared to 100 ms, indicating an enhancement of
the startle reflex known as facilitation [16]. This facilita-
tion with a 50 ms gap produced a consistent“notch”in
their Gap-PPI results, as opposed to the inhibition which
was seen at all other gap durations surrounding the 50
ms gap (Figure 3). This phenomenon is found in all age
groups of this strain and could be cause by either hyper-
acusis or tinnitus. While all three groups had significant
differences between these gap durations, the oldest
group (15-17 month olds) showed the greatest difference
of percentage of inhibition between 50 ms and 100 ms
gaps, with a difference of 40% (50 ms gap averaging at
11% PPI and 100 ms gap averaging at 51% PPI.
Figure 1. Paradigm of noise burst induced prepulse inhibition
(NB-PPI) and gap-induced prepulse inhibition (gap-PPI). (A) A
rat in the testing apparatus for startle response test. (B) The startle
amplitude-level function recorded from a group of 3-5 months old
rats. (C-D) Startle response recorded in gap-PPI test. The ampli-
tude of the startle response was significantly reduced when a silent
gap was preceding the startle sound. (E-F) Startle response record-
ed in NB-PPI. The amplitude of the startle response was signifi-
cantly reduced when a noise-burst was preceding the startle sound.
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When the startle stimulus for the Gap-PPI testing was
reduced from 105 dB SPL to 95 dB SPL, the notch was
eliminated and inhibition occurred across all pre-pulse
gap durations in the 3-5 month group; meaning there was
no longer a significant difference between 50 and 100 ms
gaps (Figure 3A). The 9-12 month group and the 15-17
month group still showed a significant difference at this
point (Figures 3B-C). The greatest percentage of inhibi-
tion across the three groups remained above 60%, indicat-
ing normal responses with a reduced stimulus level. The
3-5 month group showed less facilitation at the 50 ms
gap with the 10 dB reduction in startle stimulus. This
can be seen by the improvement in inhibition from 25%
to 53% , with a 50 ms gap, as the startle stimulus was
changed from 95 dB to 85 dB. Both the 9-12 month
group and the 15-17 month group showed a significant
difference between 50 and 100 ms gaps, indicating no ef-
fect from the 10 dB SPL reduction in stimulus intensity.
Figure 3. Gap induced prepulse inhibition (gap-PPI) recorded in
different intensity of the startle sound in rats with different ages.
(A) 3-5 months, (B) 9-12 months, (C) 15-17 months. The notch
disappeared when the startle sound intensity decreased in 3-5
months and 9-12 months groups, but not in the 15-17 groups.
Figure 2. (A) Noise-burst induced acoustic startle reflex inhibi-
tion (NB-PPI) in three different ages of rats. (B) Gap-PPI was re-
corded in all ages of F-344 rats with different gap durations
(1-100 ms). Reduced gap-PPI amplitude was recorded at 50 ms
gap duration in all three groups.
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When the startle stimulus was reduced 10 dB fur-
ther to 85 dB SPL, none of the three groups still ex-
hibited a significant difference in inhibition percentage
between 50 and 100 ms gaps. The peak Gap-PPI am-
plitudes remained above 60% , indicating normal re-
sponses when the stimulus level was reduced by 20
dB. The 9-12 month group and the 15-17 month
group displayed less facilitation at the 50 ms gap with
a 20 dB reduction in startle stimulus. This change is
similar to that exhibited by the 3-5 month group with
a 10 dB reduction in stimulus level. The Gap-PPI am-
plitude improved from 30% to 63% for the 9-12
month group (Figure 3B) and 12% PPI to 26% PPI
for the 15-17 month group (Figure 3C) as the stimulus
level was reduced from 95 dB to 85 dB. The middle
aged group showed a more significant increase in
Gap-PPI amplitude, indicating that the reduction in
stimulus level had a greater effect on the middle aged
group.
Effect of cholinergic receptor on sound percep-
tion: The cholinergic receptor has been closely associ-
ated with the auditory system through auditory memo-
ry and learning [4]. As previously stated, scopolamine
is associated with the functioning of the cholinergic re-
ceptors in the brain. Before testing Gap-PPI on Fisch-
er 344 rats, subcutaneous injections of scopolamine
(0.5 mg/kg) were given to all groups of rats. For the
3-5 month group, after injection of scopolamine, the
“notch” on the gap-PPI function at 50 ms was re-
duced (Figure 4A). The notch reappeared and a signif-
icant difference between the 50 and 100 ms gap was
found two days after the administration of scopol-
amine (Figure 4A). This suggests that scopolamine, an
m-type AChR antagonist, does show an acute effect on
loudness response in the young rats. For the 9-12
month and 15-17 month old groups, gap-PPI results af-
ter acute injections of scopolamine still displayed a sig-
nificant difference between 50 and 100 ms gaps, simi-
lar to those in the baseline testing. Subsequent testing
was conducted on the second day and the third day re-
vealed similar results (Figures 4B-C). This indicates
that scopolamine has no significant effect on the 50
ms gap facilitation or inhibition in old groups.
When the n-type AChR antagonist, mecamylamine,
was used in the same conditions, no significant chang-
es were found in Gap-PPI amplitude results for either
the 9-12 or 15-17 month old group (Figure 4D). This
indicated that either the cholinergic receptors are not
involved in the sensation of hyperacusis or mecamyla-
mine has no significant effect on this hyperacusis-like




Age induced hypersensitivity to sound: Reduced
gap-PPI, which can be caused by the facilitation of
acoustic startle response[17], was induced by a 50 ms gap
in all age groups. This facilitation indicates that the rats
responded more to the startle when there was a prepulse
stimulus. This could be caused by a hyperacusis effect
seen with only the 50 ms gap or due to tinnitus. If the
notch is explainable by tinnitus, then the silent gaps situ-
ated before the startle stimulus would be filled by the tin-
nitus and prevent the rat from hearing the warning and
therefore respond more greatly to the startle stimulus. If
the notch was due to a hyperacusis effect, the rat may be
more sensitive to the startle stimulus and therefore have
a more robust response in this condition.
This notch was nearly eliminated, meaning Inhibition
was increased, when the startle stimulus was reduced by
10 dB for young rats and 20 dB for middle aged and old
rats. For the young rats, a meager 10 dB reduction in the
intensity of the startle stimulus greatly reduced their reac-
tion to the startle stimulus, resulting in an elimination of
the 50 ms notch. This may indicate that these young rats
showed hyperexcitability to the more intense stimulus
and this reaction was eliminated by the reduction in
sound intensity. In order to accomplish the same results
for the middle aged group, the intensity of the startle
stimulus needed to be reduced by 20 dB SPL. However,
when the stimulus was decreased by 20 dB, the resulting
reaction was far less than the more intense stimulus and
consequently eliminated the notch as well. Twenty dB
SPL in reduction of the startle stimulus was also neces-
sary for the hyperexcitability to subside in the 15-17
month old rats. This reduction allowed them to have
less reaction to the startle and therefore eliminated the
50 ms notch. This overall pattern may imply that as
these Fischer 344 rats age, the hyperacusis sensation be-
comes more severe.
Effect of cholinergic receptor on sound processing:
The acetylcholine receptor antagonists, scopolamine and
mecamylamine, did not show any significant effect on
the gap-PPI response at 50 ms for the middle age and old
rats. However, scopolamine did show some positive ef-
fects on the gap-PPI results for the youngest group on
day 1 and 2 of injections. This positive effect was seen
by an elimination of the 50 ms notch seen with baseline
testing. Considering that this reaction was only seen on
same day and the second day after scopolamine injec-
tions, but was not reproduced in the third day of testing,
it is likely that either this drug does not have any long
term effects on the hyperacusis.
The results from the age related portion of this study
may provide a starting point for the development of a be-
havioral method of measuring hyperacusis in an animal
model. More thorough testing is necessary to justify this
testing method. The negative results from the acetylcho-
line receptor testing could be due to a variety of factors
including the method of injection or the area of the brain
that was focused on. The GABA inhibitory system may
also be associated with tinnitus and could be another ar-
ea to test in the future. The injection method could be
changed to a local application to eliminate any effects on
other areas of the body, which could in turn affect the be-
havioral responses during testing. Further development
and use of this method for measuring hyperacusis may
assist in specifying the physiological mechanism behind
this disorder.
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